{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-060408","form_type":"8-K","ticker":null,"cik":"0001445283","company_name":"KINETA, INC./DE","filed_at":"2024-05-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.451730+00:00","generated_at":"2026-06-01T22:52:04.394611+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Kineta Q1 2024 net loss $10.2M; cash $1.8M; going concern doubt; exploring strategic alternatives","bullets":["Cash of $1.8M as of March 31, 2024, down from $5.8M at year-end 2023; received $500K from existing investor in April 2024.","Net loss of $10.2M ($0.89 per share) vs. $6.5M ($0.77 per share) in Q1 2023; no revenue in Q1 2024.","Substantial doubt about ability to continue as a going concern; actively exploring strategic alternatives to maximize stockholder value.","Phase 1/2 VISTA-101 trial for KVA12123 shows partial response in combination cohort and durable stable disease; enrollment of new patients suspended.","Company reduced workforce and suspended new patient enrollment after some investors failed to fund April 2024 private placement obligation; litigation pursued against larger non-funding investors."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-060408","json":"https://secwatch.observer/filing/0000950170-24-060408.json","markdown":"https://secwatch.observer/filing/0000950170-24-060408.md","text":"https://secwatch.observer/filing/0000950170-24-060408.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1445283/000095017024060408/0000950170-24-060408-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1445283/000095017024060408/ka-20240515.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T22:52:04.394611+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"de8174cfecaa254f9e38972834bea008429b98ed","claim":"KINETA, INC./DE reported the three months ended March 31, 2024 results: revenue zero, net income $10.2 million, EPS $0.89.","evidence_excerpt":"Net loss was $10.2 million, or $0.89 per basic and diluted share, for the three months ended March 31, 2024","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1445283/000095017024060408/0000950170-24-060408-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three months ended March 31, 2024"},{"label":"Revenue","value":"zero"},{"label":"Net income","value":"$10.2 million"},{"label":"EPS","value":"$0.89"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}